Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001477932-19-004048
Filing Date
2019-07-12
Accepted
2019-07-12 17:14:49
Documents
60
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K nbio_10k.htm 10-K 447755
2 CERTIFICATION nbio_ex311.htm EX-31.1 7847
3 CERTIFICATION nbio_ex312.htm EX-31.2 7829
4 CERTIFICATION nbio_ex321.htm EX-32.1 3614
5 CERTIFICATION nbio_ex322.htm EX-32.2 3592
  Complete submission text file 0001477932-19-004048.txt   2727811

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nbio-20190331.xml EX-101.INS 434355
7 XBRL TAXONOMY EXTENSION SCHEMA nbio-20190331.xsd EX-101.SCH 51254
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nbio-20190331_cal.xml EX-101.CAL 31165
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nbio-20190331_def.xml EX-101.DEF 147115
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbio-20190331_lab.xml EX-101.LAB 218461
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbio-20190331_pre.xml EX-101.PRE 210780
Mailing Address 6330 NANCY RIDGE DR. SUITE 105 SAN DIEGO CA 92121
Business Address 6330 NANCY RIDGE DR. SUITE 105 SAN DIEGO CA 92121 612-961-5656
Nascent Biotech Inc. (Filer) CIK: 0001622057 (see all company filings)

EIN.: 450612715 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 000-55299 | Film No.: 19953549
SIC: 2834 Pharmaceutical Preparations